K. Robin Yabroff
YOU?
Author Swipe
View article: County‐level medical debt and treatment initiation among individuals newly diagnosed with cancer
County‐level medical debt and treatment initiation among individuals newly diagnosed with cancer Open
Background The high costs of cancer care may lead to medical debt for patients and families. This study examined the association of county‐level medical debt and timely treatment initiation among individuals newly diagnosed with cancer. Me…
View article: Associations of Partner Cancer History With Access to Care Among Older Adults in the U.S.
Associations of Partner Cancer History With Access to Care Among Older Adults in the U.S. Open
View article: Federal Housing Assistance and Stage at Cancer Diagnosis Among Older Adults in the US
Federal Housing Assistance and Stage at Cancer Diagnosis Among Older Adults in the US Open
Importance A growing number of older adults live in unaffordable and unstable housing; however, whether programs designed to counter housing insecurity contribute to earlier-stage cancer diagnosis remains largely unknown. Objective To exam…
View article: Transportation barriers, emergency department use, and mortality risk among us adults: a national health interview survey analysis
Transportation barriers, emergency department use, and mortality risk among us adults: a national health interview survey analysis Open
Objectives To estimate the prevalence of transportation barriers to care among patients with common chronic health conditions and examine associations between transportation barriers with the outcomes of emergency department use and all-ca…
View article: Supplementary Table 8 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 8 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Supplementary Table 8. Cancer Screening, US Adults, by State, 2020, 2022
View article: Supplementary Table 3 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 3 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Prevalence of Cigarette Smoking and Quit Ratio, US Adults, by State, 2023
View article: Supplementary Table 5 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 5 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Prevalence of Other Tobacco Product Use, US Adults, 2023
View article: Correction: Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Correction: Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
View article: Supplementary Table 6 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 6 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Supplementary Table 6. Excess body weight, Dietary patterns, Physical Activity, US Adults, by State, 2021 and 2023
View article: Supplementary Table 7 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 7 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Supplementary Table 7. Up-to-date HPV Vaccination, Adolescents, 13-17 years, by State, 2023
View article: Supplementary Table 2 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 2 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Change in cancer risk factors, HPV vaccination, and screening, 2019 to 2023, US
View article: Supplementary Table 4 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 4 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Supplementary Table 4. Smoking Cessation and Cessation Assistance Prevalence, US Adults, 2022
View article: Supplementary Table 1 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 1 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Data sources and measures
View article: Zero-premium Medicare Advantage plans: trends in areas with socioeconomic vulnerability and health needs
Zero-premium Medicare Advantage plans: trends in areas with socioeconomic vulnerability and health needs Open
Introduction Zero-premium Medicare Advantage (MA) plans are increasingly popular, yet knowledge gaps exist regarding their distribution, enrollment, and quality, particularly in areas with greater socioeconomic vulnerability and clinical n…
View article: Trade-offs in the context of cancer treatment advances: debt or death or both?
Trade-offs in the context of cancer treatment advances: debt or death or both? Open
View article: Social determinant of health patterns and mortality outcomes in US adults
Social determinant of health patterns and mortality outcomes in US adults Open
Background Social Determinants of Health (SDOH) influences healthcare access, especially in patients with chronic diseases. However, SDOHs were often investigated as single variables. Combination patterns and joint effects of multiple SDOH…
View article: Immune Checkpoint Inhibitors and Survival Disparities by Health Insurance Coverage Among Patients With Metastatic Cancer
Immune Checkpoint Inhibitors and Survival Disparities by Health Insurance Coverage Among Patients With Metastatic Cancer Open
Importance The introduction of immune checkpoint inhibitors (ICIs) has been associated with substantial improvement in median survival among individuals with cancer; however, people without health insurance coverage may be unable to afford…
View article: Supplementary Table 1 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 1 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Data sources and measures
View article: Supplementary Table 5 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 5 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Prevalence of Other Tobacco Product Use, US Adults, 2023
View article: Supplementary Table 4 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 4 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Supplementary Table 4. Smoking Cessation and Cessation Assistance Prevalence, US Adults, 2022
View article: Supplementary Table 2 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 2 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Change in cancer risk factors, HPV vaccination, and screening, 2019 to 2023, US
View article: Supplementary Table 3 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 3 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Prevalence of Cigarette Smoking and Quit Ratio, US Adults, by State, 2023
View article: Supplementary Table 8 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 8 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Supplementary Table 8. Cancer Screening, US Adults, by State, 2020, 2022
View article: Supplementary Table 6 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 6 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Supplementary Table 6. Excess body weight, Dietary patterns, Physical Activity, US Adults, by State, 2021 and 2023
View article: Data from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Data from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
This study presents national- and state-level prevalence of major modifiable cancer risk factors, human papillomavirus vaccination, and cancer screenings among US adults in the years during and after the COVID-19 pandemic compared with pre…
View article: Supplementary Table 7 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Supplementary Table 7 from Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update Open
Supplementary Table 7. Up-to-date HPV Vaccination, Adolescents, 13-17 years, by State, 2023
View article: Cancer treatment and survivorship statistics, 2025
Cancer treatment and survivorship statistics, 2025 Open
The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the pub…
View article: Short-Term Limited Duration Insurance Plan Policies and Cancer Stage at Diagnosis
Short-Term Limited Duration Insurance Plan Policies and Cancer Stage at Diagnosis Open
Importance Many short-term limited duration (STLD) insurance plans do not cover essential health benefits, such as cancer screenings, potentially delaying diagnoses. In October 2018, federal regulations loosened restrictions on STLD plans …
View article: Prior Authorization, Quantity Limits, and Costs for Varenicline in Medicare
Prior Authorization, Quantity Limits, and Costs for Varenicline in Medicare Open
This cross-sectional study of national data on Part D and Medicare Advantage prescription drug plans compares utilization management and plan-level patient out-of-pocket costs for varenicline in smoking cessation treatment.
View article: Contemporary Patterns of End-of-Life Care Among Medicare Beneficiaries With Advanced Cancer
Contemporary Patterns of End-of-Life Care Among Medicare Beneficiaries With Advanced Cancer Open
Importance Considerable efforts have been dedicated to improving the quality of end-of-life care among patients with advanced cancer in the past decade. Whether the quality has shifted in response to these efforts remains unknown. Objectiv…